COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,093 Articles (22,658 medRxiv, 8,435 bioRxiv)

Most recent first Previous |  Page 1661: Articles 16601-16610  | Next

Characteristics of Long Covid: findings from a social media surve
Ziauddeen, N., Gurdasani, D., O'Hara, M. E., Hastie, C., Roderick, P., Yao, G., Alwan, N. A.
10.1101/2021.03.21.21253968 — Posted: 2021-03-26
Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance
Reiterer, M., Rajan, M., Gomez-Banoy, N., Lau, J. D., Gomez-Escobar, L. G., Gilani, A., Alvarez-Mullet, S., Sholle, E. T., Chandar, V., Bram, Y., Hoffman, K., Rubio-Navarro, A., Uhl, S., Shukla, A. P., Goyal, P., tenOever, B. R., Alonso, L., Schwartz, R. E., Schenck, E. J., Safford, M. M., Lo, J. C.
10.1101/2021.03.21.21254072 — Posted: 2021-03-26
The vaccine-elicited immunoglobulin profile in milk after COVID-19 mRNA-based vaccination is IgG-dominant and lacks secretory antibodies
Fox, A., Norris, C., Amanat, F., Zolla-Pazner, S., Powell, R. L.
10.1101/2021.03.22.21253831 — Posted: 2021-03-26 Discussion: Onsite
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
Teyssou, E., Soulie, C., Visseaux, B., Lambert-Niclot, S., Ferre, V., Marot, S., Jary, A., Sayon, S., Zafilaza, K., Leducq, V., Schnuriger, A., Wirdern, M., Houhou-Fidouh, N., Charpentier, C., Morand-Joubert, L., Burrel, S., Descamps, D., Calvez, V., Marcelin, A.-G.
10.1101/2021.03.21.21253498 — Posted: 2021-03-26
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status
Eyre, D. W., Lumley, S. F., Wei, J., Cox, S., James, T., Justice, A., Jesuthasan, G., O'Donnell, D., Howarth, A., Hatch, S. B., Marsden, B. D., Jones, E. Y., Stuart, D. I., Ebner, D., Hoosdally, S., Crook, D., Peto, T. E., Walker, T. M., Stoesser, N. E., Matthews, P. C., Pouwels, K. B., Walker, A. S., Jeffery, K.
10.1101/2021.03.21.21254061 — Posted: 2021-03-26 Discussion: Onsite
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking
Chen, H., Li, Z., Feng, S., Wang, A., Richard-Greenblatt, M., Hutson, E., Andrianus, S., Glaser, L., Rodino, K. G., Qian, J., Jayaraman, D., Collman, R., Glascock, A. L., Bushman, F., Lee, J. S., Cherry, S., Fausto, A., Weiss, S. R., Koo, H., Corby, P. M., ODoherty, U., Garfall, A. L., Vogl, D. T., Stadtmauer, E. A., Wang, P.
10.1101/2021.03.17.21253847 — Posted: 2021-03-26
Localised community circulation of SARS-CoV-2 viruses with an increased accumulation of single nucleotide polymorphisms that adversely affect the sensitivity of real-time reverse transcription assays targeting Nucleocapsid protein.
Moore, C., Davies, L., Rees, R., Gifford, L., Lewis, H., Plimmer, A., Mack, A., Pacchiarini, N., Southgate, J. A., The COVID-19 Genomics UK (COG-UK) consortium, , Bull, M. J., Watkins, J., Corden, S., Connor, T. R.
10.1101/2021.03.22.21254006 — Posted: 2021-03-26
Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information
Rando, H. M., Bennett, T. D., Byrd, J. B., Bramante, C., Callahan, T. J., Chute, C. G., Davis, H., Deer, R., Gagnier, J., Koraishy, F. M., Liu, F., McMurry, J. A., Moffitt, R. A., Pfaff, E. R., Reese, J. T., Relevo, R., Robinson, P. N., Saltz, J. H., Solomonides, A., Sule, A., Topaloglu, U., Haendel, M. A.
10.1101/2021.03.20.21253896 — Posted: 2021-03-26
Reportable range of quantitative assays for SARS-CoV-2 antibodies determination. An overlooked issue?
Dittadi, R., Bertoli, I., Carraro, P.
10.1101/2021.03.21.21254043 — Posted: 2021-03-26
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 infection severity
FREITAS, A. T., Calhau, C., Antunes, G., Araujo, B., Bandeira, M., Barreira, S., Bazenga, F., Braz, S., Caldeira, D., Santos, S. C. R., Faria, A., Faria, D., Fraga, M., Nogueira-Garcia, B., Goncalves, L., Kovalchuk, P., Lacerda, L., Lopes, H., Luis, D., Medeiros, F., Melo, A. M., Melo-Cristino, J., Miranda, A., Pereira, C., Pinto, A. T., Pinto, J., Proenca, H., Ramos, A., Rato, J. P., Rocha, F., Rocha, J. C., Moreira-Rosario, A., Vazao, H., Volovetska, Y., Guimaraes, J.-T., Pinto, F.
10.1101/2021.03.22.21254032 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).